Overview Prophylaxis of Post-ERCP Acute Pancreatitis Status: Recruiting Trial end date: 2025-02-01 Target enrollment: Participant gender: Summary This study aims to compare indomethacin and the combination of indomethacin and aggressive lactated Ringer infusion in terms of efficacy in preventing post-ERCP acute pancreatitis (PEP). Phase: Phase 3 Details Lead Sponsor: Azienda Unità Sanitaria Locale Reggio EmiliaTreatments: Indomethacin